000			01743nam a2200397 a 4500
001			EBC1098891
003			MiAaPQ
005			20240120134258.0
006			m o d |
007			cr cn|||||||||
008			120522s2013 njua sb 001 0 eng d
010			_z 2012020857
020			_z9780470924310 (cloth)
020			_a9781118356784 (electronic bk.)
035			_a(MiAaPQ)EBC1098891
035			_a(Au-PeEL)EBL1098891
035			_a(CaPaEBR)ebr10639275
035			_a(CaONFJC)MIL420582
035			_a(OCoLC)794306445
040			_aMiAaPQ _cMiAaPQ _dMiAaPQ
050		4	_aQP99.3.P7 _bP76 2013
082	0	4	_a615.3/9 _223
245	0	0	_aProduction of plasma proteins for therapeutic use _h[electronic resource] / _cedited by Joseph Bertolini, Neil Goss, John Curling.
260			_aHoboken, N.J. : _bJohn Wiley & Sons, _cc2013.
300			_axii, 496 p. : _bill.
504			_aIncludes bibliographical references and index.
505	0		_asection 1. Introduction to plasma fractionation -- section 2. Plasma proteins for therapeutic use -- section 3. Pathogen safety of plasma products -- section 4. The pharmaceutical environment applied to plasma fractionation -- section 5. The market for plasma products and the economics of fractionation.
533			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650		0	_aBlood proteins _xTherapeutic use.
655		4	_aElectronic books.
700	1		_aBertolini, Joseph.
700	1		_aGoss, Neil.
700	1		_aCurling, J. M. _q(John M.)
710	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=1098891 _zClick to View
999			_c88662 _d88662